Nalu Medical

Nalu Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $120M

Overview

Nalu Medical is a clinical-stage medical device company pioneering a novel, miniaturized neurostimulation system for chronic pain management. Its core innovation is a non-integrated, battery-free microstimulator that is significantly smaller than traditional implantable pulse generators (IPGs), aiming to reduce surgical burden and offer greater patient flexibility. The company has a commercially focused product and is led by an experienced management team with deep roots in major medtech firms. Nalu operates in the large and growing chronic pain market, competing against established neuromodulation players with a potentially disruptive form factor and upgrade path.

Chronic PainNeuroscience

Technology Platform

A miniaturized, non-integrated, battery-free neurostimulation system consisting of an implanted micro-stimulator, a separate electrode array, and an externally worn, upgradeable Therapy Disc that powers the implant wirelessly.

Funding History

3
Total raised:$120M
Series C$65M
Series B$35M
Series A$20M

Opportunities

The large and growing chronic pain market, driven by the opioid crisis and aging population, presents a significant addressable opportunity.
Nalu's miniaturized, battery-free, and upgradeable system offers a compelling value proposition that could capture market share from larger, less flexible incumbent devices.
The platform technology also has potential for expansion into other neuromodulation indications beyond chronic pain.

Risk Factors

Key risks include the challenge of generating robust clinical data to drive physician adoption against established competitors, the execution risk of building a commercial organization and securing reimbursement, and the competitive threat from large incumbents who could develop similar miniaturized technology.

Competitive Landscape

Nalu competes in the neuromodulation for pain market against large, established players like Medtronic, Boston Scientific, Abbott, and Nevro, who market traditional implantable pulse generators (IPGs). Nalu's primary competitive differentiation is its drastically smaller size, battery-free design, and upgradable external component, which together aim to reduce surgical burden and future-proof the therapy.